Atlas/Check my plan

How does your package compare?

Five quick answers. Your plan is scored live against every approved precedent in your modality, with the regulator's sentence behind each finding.

01What are you developing?

We'll compare you with every approved product in this modality.

02Which species for pivotal tox?

Pick all that apply.

03Longest pivotal study

Each dot is an approved small molecule. Drag to place yourself.

39 wk

1 wk39 wk78 wk

Longer than 86 of 211 precedents · median 39 wk

04Which studies are you planning?

Toggle the ones in your plan.

05How will you set the first human dose?

We'll show the precedents that disclosed their approach.

Precedent fit · Small molecules

Well within precedent

4 aligned · 3 heads-up · 0 differ

Species. 1 of 211 approved small molecules used the same set-up (monkey only). Most common: rodent + dog or minipig (121).Evidence:

✓

Study length. You plan 39 weeks; precedents ran 1–78 (median 39).Evidence: , ,

✓

Genotoxicity studies. Your choice matches the majority: 210 of 211 precedents did the same.Evidence: , ,

✓

A carcinogenicity study. Your choice matches the majority: 113 of 211 precedents did the same.Evidence: , ,

✓

Dedicated reproductive tox. Your choice matches the majority: 203 of 211 precedents did the same.Evidence: , ,

First human dose. 0 of 211 small molecules disclosed how they set it. Decide early — it drives which tox data you need.

What reviewers will probe. Mutagenicity of ferric maltol and maltol in Ames assays · Major human metabolites · Corticosteroid class toxicities: adrenal cortical atrophyEvidence: , ,